New York State Common Retirement Fund’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-46,558
| Closed | -$3.17M | – | 3291 |
|
|
2022
Q3 | $3.17M | Buy |
46,558
+1,611
| +4% | +$88.8K | ﹤0.01% | 1379 |
|
|
2022
Q2 | $1.44M | Buy |
44,947
+1,395
| +3% | +$40.8K | ﹤0.01% | 1837 |
|
|
2022
Q1 | $1.51M | Buy |
43,552
+482
| +1% | +$14.4K | ﹤0.01% | 1895 |
|
|
2021
Q4 | $1.26M | Sell |
43,070
-144
| -0.3% | -$4.46K | ﹤0.01% | 2019 |
|
|
2021
Q3 | $1.1M | Sell |
43,214
-8,386
| -16% | -$246K | ﹤0.01% | 2071 |
|
|
2021
Q2 | $1.81M | Sell |
51,600
-13,200
| -20% | -$515K | ﹤0.01% | 1932 |
|
|
2021
Q1 | $2.64M | Sell |
64,800
-11,000
| -15% | -$506K | ﹤0.01% | 1617 |
|
|
2020
Q4 | $3.28M | Sell |
75,800
-17,426
| -19% | -$859K | ﹤0.01% | 1433 |
|
|
2020
Q3 | $5.14M | Buy |
93,226
+600
| +0.6% | +$38.1K | 0.01% | 1150 |
|
|
2020
Q2 | $5.85M | Buy |
92,626
+32,467
| +54% | +$2.23M | 0.01% | 1098 |
|
|
2020
Q1 | $3.07M | Sell |
60,159
-983
| -2% | -$65.8K | ﹤0.01% | 1240 |
|
|
2019
Q4 | $4.86M | Sell |
61,142
-4,785
| -7% | -$284K | 0.01% | 1265 |
|
|
2019
Q3 | $3.2M | Buy |
65,927
+459
| +0.7% | +$23.9K | ﹤0.01% | 1416 |
|
|
2019
Q2 | $3.44M | Buy |
65,468
+4,500
| +7% | +$259K | ﹤0.01% | 1406 |
|
|
2019
Q1 | $3.23M | Buy |
60,968
+11,968
| +24% | +$588K | ﹤0.01% | 1407 |
|
|
2018
Q4 | $2.01M | Sell |
49,000
-12,478
| -20% | -$468K | ﹤0.01% | 1551 |
|
|
2018
Q3 | $2.34M | Hold |
61,478
| – | – | ﹤0.01% | 1597 |
|
|
2018
Q2 | $2.78M | Buy |
61,478
+13,720
| +29% | +$625K | ﹤0.01% | 1508 |
|
|
2018
Q1 | $2.31M | Buy |
47,758
+2,000
| +4% | +$112K | ﹤0.01% | 1549 |
|
|
2017
Q4 | $1.8M | Buy |
45,758
+6,258
| +16% | +$234K | ﹤0.01% | 1703 |
|
|
2017
Q3 | $1.23M | Hold |
39,500
| – | – | ﹤0.01% | 1905 |
|
|
2017
Q2 | $1.08M | Buy |
39,500
+20,012
| +103% | +$595K | ﹤0.01% | 1997 |
|
|
2017
Q1 | $718K | Sell |
19,488
-712
| -4% | -$17.9K | ﹤0.01% | 2201 |
|
|
2016
Q4 | $292K | Hold |
20,200
| – | – | ﹤0.01% | 2625 |
|
|
2016
Q3 | $466K | Buy |
20,200
+5,800
| +40% | +$111K | ﹤0.01% | 2348 |
|
|
2016
Q2 | $239K | Buy |
14,400
+7,200
| +100% | +$145K | ﹤0.01% | 2648 |
|
|
2016
Q1 | $114K | Hold |
7,200
| – | – | ﹤0.01% | 2891 |
|
|
2015
Q4 | $233K | Buy |
+7,200
| New | +$312K | ﹤0.01% | 2690 |
|
Other funds holding GBT
New York State Common Retirement Fund's GBT Position: Q4 2022 in Review
New York State Common Retirement Fund sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 46,558 shares — an estimated $3.17M sold.
New York State Common Retirement Fund first reported a position in GBT in Q4 2015 and held it in 28 quarters. The position peaked at $5.85M in Q2 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- New York State Common Retirement Fund reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- New York State Common Retirement Fund sold 46,558 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3.17M.
- New York State Common Retirement Fund first reported a position in Global Blood Therapeutics, Inc. in Q4 2015 and held it in 28 quarters.
- New York State Common Retirement Fund's Global Blood Therapeutics, Inc. position peaked at $5.85M in Q2 2020.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on New York State Common Retirement Fund's 13F filing for Q4 2022, filed 30 Jan 2023.